| UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
|||||||
|
Fusion Protein:INTS3-CHTOP |
Fusion Protein Summary |
 Fusion gene summary |
| Fusion partner gene information | Fusion gene name: INTS3-CHTOP | FusionPDB ID: 39936 | FusionGDB2.0 ID: 39936 | Hgene | Tgene | Gene symbol | INTS3 | CHTOP | Gene ID | 65123 | 26097 |
| Gene name | integrator complex subunit 3 | chromatin target of PRMT1 | |
| Synonyms | C1orf193|C1orf60|INT3|SOSS-A|SOSSA | C10orf77|C1orf77|FL-SRAG|FOP|SRAG|SRAG-3|SRAG-5|pp7704 | |
| Cytomap | 1q21.3 | 1q21.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | integrator complex subunit 3SOSS complex subunit Asensor of single-strand DNA complex subunit Asensor of ssDNA subunit A | chromatin target of PRMT1 proteinfriend of PRMT1 proteinsmall protein rich in arginine and glycine | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q68E01 | Q9Y3Y2 | |
| Ensembl transtripts involved in fusion gene | ENST ids | ENST00000476843, ENST00000318967, ENST00000435409, ENST00000456435, ENST00000512605, | ENST00000368694, ENST00000368686, ENST00000368687, ENST00000368690, ENST00000403433, ENST00000495554, |
| Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 6 X 7 X 4=168 | 5 X 7 X 5=175 |
| # samples | 8 | 8 | |
| ** MAII score | log2(8/168*10)=-1.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/175*10)=-1.12928301694497 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context (manual curation of fusion genes in FusionPDB) | PubMed: INTS3 [Title/Abstract] AND CHTOP [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | INTS3(153730239)-CHTOP(153614719), # samples:3 | ||
| Anticipated loss of major functional domain due to fusion event. | INTS3-CHTOP seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. INTS3-CHTOP seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | INTS3 | GO:0016180 | snRNA processing | 16239144 |
| Tgene | CHTOP | GO:0006406 | mRNA export from nucleus | 23299939 |
| Tgene | CHTOP | GO:0032781 | positive regulation of ATPase activity | 23299939 |
| Tgene | CHTOP | GO:0051096 | positive regulation of helicase activity | 23299939 |
| Fusion gene breakpoints across INTS3 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across CHTOP (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
Top |
Fusion Gene Sample Information |
| Fusion gene information from FusionGDB2.0. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | SARC | TCGA-WK-A8XY-01A | INTS3 | chr1 | 153730239 | - | CHTOP | chr1 | 153614719 | + |
| ChimerDB4 | THCA | TCGA-EM-A3FO-01A | INTS3 | chr1 | 153730239 | - | CHTOP | chr1 | 153614719 | + |
| ChimerDB4 | THCA | TCGA-EM-A3FO-01A | INTS3 | chr1 | 153730239 | + | CHTOP | chr1 | 153614719 | + |
| ChimerDB4 | THCA | TCGA-EM-A3FO-01A | INTS3 | chr1 | 153730239 | + | CHTOP | chr1 | 153614722 | + |
| ChimerDB4 | THCA | TCGA-EM-A3FO | INTS3 | chr1 | 153730239 | + | CHTOP | chr1 | 153614718 | + |
| ChimerKB4 | . | . | INTS3 | chr1 | 153731481 | + | CHTOP | chr1 | 153613385 | + |
Top |
Fusion ORF Analysis |
| Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000456435 | INTS3 | chr1 | 153730239 | + | ENST00000368694 | CHTOP | chr1 | 153614718 | + | 3282 | 1717 | 538 | 2244 | 568 |
| ENST00000318967 | INTS3 | chr1 | 153730239 | + | ENST00000368694 | CHTOP | chr1 | 153614718 | + | 3282 | 1717 | 538 | 2244 | 568 |
| ENST00000435409 | INTS3 | chr1 | 153730239 | + | ENST00000368694 | CHTOP | chr1 | 153614718 | + | 2917 | 1352 | 173 | 1879 | 568 |
| ENST00000512605 | INTS3 | chr1 | 153730239 | + | ENST00000368694 | CHTOP | chr1 | 153614718 | + | 2371 | 806 | 251 | 1333 | 360 |
| ENST00000456435 | INTS3 | chr1 | 153730239 | + | ENST00000368694 | CHTOP | chr1 | 153614722 | + | 3282 | 1717 | 538 | 2244 | 568 |
| ENST00000318967 | INTS3 | chr1 | 153730239 | + | ENST00000368694 | CHTOP | chr1 | 153614722 | + | 3282 | 1717 | 538 | 2244 | 568 |
| ENST00000435409 | INTS3 | chr1 | 153730239 | + | ENST00000368694 | CHTOP | chr1 | 153614722 | + | 2917 | 1352 | 173 | 1879 | 568 |
| ENST00000512605 | INTS3 | chr1 | 153730239 | + | ENST00000368694 | CHTOP | chr1 | 153614722 | + | 2371 | 806 | 251 | 1333 | 360 |
| ENST00000456435 | INTS3 | chr1 | 153730239 | + | ENST00000368694 | CHTOP | chr1 | 153614719 | + | 3282 | 1717 | 538 | 2244 | 568 |
| ENST00000318967 | INTS3 | chr1 | 153730239 | + | ENST00000368694 | CHTOP | chr1 | 153614719 | + | 3282 | 1717 | 538 | 2244 | 568 |
| ENST00000435409 | INTS3 | chr1 | 153730239 | + | ENST00000368694 | CHTOP | chr1 | 153614719 | + | 2917 | 1352 | 173 | 1879 | 568 |
| ENST00000512605 | INTS3 | chr1 | 153730239 | + | ENST00000368694 | CHTOP | chr1 | 153614719 | + | 2371 | 806 | 251 | 1333 | 360 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000456435 | ENST00000368694 | INTS3 | chr1 | 153730239 | + | CHTOP | chr1 | 153614718 | + | 0.003968544 | 0.99603146 |
| ENST00000318967 | ENST00000368694 | INTS3 | chr1 | 153730239 | + | CHTOP | chr1 | 153614718 | + | 0.003968544 | 0.99603146 |
| ENST00000435409 | ENST00000368694 | INTS3 | chr1 | 153730239 | + | CHTOP | chr1 | 153614718 | + | 0.005196815 | 0.99480313 |
| ENST00000512605 | ENST00000368694 | INTS3 | chr1 | 153730239 | + | CHTOP | chr1 | 153614718 | + | 0.02094655 | 0.97905344 |
| ENST00000456435 | ENST00000368694 | INTS3 | chr1 | 153730239 | + | CHTOP | chr1 | 153614722 | + | 0.003968544 | 0.99603146 |
| ENST00000318967 | ENST00000368694 | INTS3 | chr1 | 153730239 | + | CHTOP | chr1 | 153614722 | + | 0.003968544 | 0.99603146 |
| ENST00000435409 | ENST00000368694 | INTS3 | chr1 | 153730239 | + | CHTOP | chr1 | 153614722 | + | 0.005196815 | 0.99480313 |
| ENST00000512605 | ENST00000368694 | INTS3 | chr1 | 153730239 | + | CHTOP | chr1 | 153614722 | + | 0.02094655 | 0.97905344 |
| ENST00000456435 | ENST00000368694 | INTS3 | chr1 | 153730239 | + | CHTOP | chr1 | 153614719 | + | 0.003968544 | 0.99603146 |
| ENST00000318967 | ENST00000368694 | INTS3 | chr1 | 153730239 | + | CHTOP | chr1 | 153614719 | + | 0.003968544 | 0.99603146 |
| ENST00000435409 | ENST00000368694 | INTS3 | chr1 | 153730239 | + | CHTOP | chr1 | 153614719 | + | 0.005196815 | 0.99480313 |
| ENST00000512605 | ENST00000368694 | INTS3 | chr1 | 153730239 | + | CHTOP | chr1 | 153614719 | + | 0.02094655 | 0.97905344 |
Top |
Fusion Amino Acid Sequences |
| For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >39936_39936_1_INTS3-CHTOP_INTS3_chr1_153730239_ENST00000318967_CHTOP_chr1_153614718_ENST00000368694_length(amino acids)=568AA_BP=393 MTFSRLLAAAMELQKGKGAAAAAAASGAAGGGGGGAGAGAPGGGRLLLSTSLDAKDELEERLERCMSIVTSMTAGVSEREANDALNAYVC KGLPQHEEICLGLFTLILTEPAQAQKCYRDLALVSRDGMNIVLNKINQILMEKYLKLQDTCRTQLVWLVRELVKSGVLGADGVCMTFMKQ IAGGDVTAKNIWLAESVLDILTEQREWVLKSSILIAMAVYTYLRLIVDHHGTAQLQALRQKEVDFCISLLRERFMECLMIGRDLVRLLQN VARIPEFELLWKDIIHNPQALSPQFTGILQLLQSRTSRKFLACRLTPDMETKLLFMTSRVRFGQQKRYQDWFQRQYLSTPDSQSLRCDLI RYICGVVHPSNEVLSSDILPRWAIIGWLLTTCTSLKQRLGKSNIQARLGRPIGALARGAIGGRGLPIIQRGLPRGGLRGGRATRTLLRGG MSLRGQNLLRGGRAVAPRMGLRRGGVRGRGGPGRGGLGRGAMGRGGIGGRGRGMIGRGRGGFGGRGRGRGRGRGALARPVLTKEQLDNQL -------------------------------------------------------------- >39936_39936_2_INTS3-CHTOP_INTS3_chr1_153730239_ENST00000318967_CHTOP_chr1_153614719_ENST00000368694_length(amino acids)=568AA_BP=393 MTFSRLLAAAMELQKGKGAAAAAAASGAAGGGGGGAGAGAPGGGRLLLSTSLDAKDELEERLERCMSIVTSMTAGVSEREANDALNAYVC KGLPQHEEICLGLFTLILTEPAQAQKCYRDLALVSRDGMNIVLNKINQILMEKYLKLQDTCRTQLVWLVRELVKSGVLGADGVCMTFMKQ IAGGDVTAKNIWLAESVLDILTEQREWVLKSSILIAMAVYTYLRLIVDHHGTAQLQALRQKEVDFCISLLRERFMECLMIGRDLVRLLQN VARIPEFELLWKDIIHNPQALSPQFTGILQLLQSRTSRKFLACRLTPDMETKLLFMTSRVRFGQQKRYQDWFQRQYLSTPDSQSLRCDLI RYICGVVHPSNEVLSSDILPRWAIIGWLLTTCTSLKQRLGKSNIQARLGRPIGALARGAIGGRGLPIIQRGLPRGGLRGGRATRTLLRGG MSLRGQNLLRGGRAVAPRMGLRRGGVRGRGGPGRGGLGRGAMGRGGIGGRGRGMIGRGRGGFGGRGRGRGRGRGALARPVLTKEQLDNQL -------------------------------------------------------------- >39936_39936_3_INTS3-CHTOP_INTS3_chr1_153730239_ENST00000318967_CHTOP_chr1_153614722_ENST00000368694_length(amino acids)=568AA_BP=393 MTFSRLLAAAMELQKGKGAAAAAAASGAAGGGGGGAGAGAPGGGRLLLSTSLDAKDELEERLERCMSIVTSMTAGVSEREANDALNAYVC KGLPQHEEICLGLFTLILTEPAQAQKCYRDLALVSRDGMNIVLNKINQILMEKYLKLQDTCRTQLVWLVRELVKSGVLGADGVCMTFMKQ IAGGDVTAKNIWLAESVLDILTEQREWVLKSSILIAMAVYTYLRLIVDHHGTAQLQALRQKEVDFCISLLRERFMECLMIGRDLVRLLQN VARIPEFELLWKDIIHNPQALSPQFTGILQLLQSRTSRKFLACRLTPDMETKLLFMTSRVRFGQQKRYQDWFQRQYLSTPDSQSLRCDLI RYICGVVHPSNEVLSSDILPRWAIIGWLLTTCTSLKQRLGKSNIQARLGRPIGALARGAIGGRGLPIIQRGLPRGGLRGGRATRTLLRGG MSLRGQNLLRGGRAVAPRMGLRRGGVRGRGGPGRGGLGRGAMGRGGIGGRGRGMIGRGRGGFGGRGRGRGRGRGALARPVLTKEQLDNQL -------------------------------------------------------------- >39936_39936_4_INTS3-CHTOP_INTS3_chr1_153730239_ENST00000435409_CHTOP_chr1_153614718_ENST00000368694_length(amino acids)=568AA_BP=393 MTFSRLLAAAMELQKGKGAAAAAAASGAAGGGGGGAGAGAPGGGRLLLSTSLDAKDELEERLERCMSIVTSMTAGVSEREANDALNAYVC KGLPQHEEICLGLFTLILTEPAQAQKCYRDLALVSRDGMNIVLNKINQILMEKYLKLQDTCRTQLVWLVRELVKSGVLGADGVCMTFMKQ IAGGDVTAKNIWLAESVLDILTEQREWVLKSSILIAMAVYTYLRLIVDHHGTAQLQALRQKEVDFCISLLRERFMECLMIGRDLVRLLQN VARIPEFELLWKDIIHNPQALSPQFTGILQLLQSRTSRKFLACRLTPDMETKLLFMTSRVRFGQQKRYQDWFQRQYLSTPDSQSLRCDLI RYICGVVHPSNEVLSSDILPRWAIIGWLLTTCTSLKQRLGKSNIQARLGRPIGALARGAIGGRGLPIIQRGLPRGGLRGGRATRTLLRGG MSLRGQNLLRGGRAVAPRMGLRRGGVRGRGGPGRGGLGRGAMGRGGIGGRGRGMIGRGRGGFGGRGRGRGRGRGALARPVLTKEQLDNQL -------------------------------------------------------------- >39936_39936_5_INTS3-CHTOP_INTS3_chr1_153730239_ENST00000435409_CHTOP_chr1_153614719_ENST00000368694_length(amino acids)=568AA_BP=393 MTFSRLLAAAMELQKGKGAAAAAAASGAAGGGGGGAGAGAPGGGRLLLSTSLDAKDELEERLERCMSIVTSMTAGVSEREANDALNAYVC KGLPQHEEICLGLFTLILTEPAQAQKCYRDLALVSRDGMNIVLNKINQILMEKYLKLQDTCRTQLVWLVRELVKSGVLGADGVCMTFMKQ IAGGDVTAKNIWLAESVLDILTEQREWVLKSSILIAMAVYTYLRLIVDHHGTAQLQALRQKEVDFCISLLRERFMECLMIGRDLVRLLQN VARIPEFELLWKDIIHNPQALSPQFTGILQLLQSRTSRKFLACRLTPDMETKLLFMTSRVRFGQQKRYQDWFQRQYLSTPDSQSLRCDLI RYICGVVHPSNEVLSSDILPRWAIIGWLLTTCTSLKQRLGKSNIQARLGRPIGALARGAIGGRGLPIIQRGLPRGGLRGGRATRTLLRGG MSLRGQNLLRGGRAVAPRMGLRRGGVRGRGGPGRGGLGRGAMGRGGIGGRGRGMIGRGRGGFGGRGRGRGRGRGALARPVLTKEQLDNQL -------------------------------------------------------------- >39936_39936_6_INTS3-CHTOP_INTS3_chr1_153730239_ENST00000435409_CHTOP_chr1_153614722_ENST00000368694_length(amino acids)=568AA_BP=393 MTFSRLLAAAMELQKGKGAAAAAAASGAAGGGGGGAGAGAPGGGRLLLSTSLDAKDELEERLERCMSIVTSMTAGVSEREANDALNAYVC KGLPQHEEICLGLFTLILTEPAQAQKCYRDLALVSRDGMNIVLNKINQILMEKYLKLQDTCRTQLVWLVRELVKSGVLGADGVCMTFMKQ IAGGDVTAKNIWLAESVLDILTEQREWVLKSSILIAMAVYTYLRLIVDHHGTAQLQALRQKEVDFCISLLRERFMECLMIGRDLVRLLQN VARIPEFELLWKDIIHNPQALSPQFTGILQLLQSRTSRKFLACRLTPDMETKLLFMTSRVRFGQQKRYQDWFQRQYLSTPDSQSLRCDLI RYICGVVHPSNEVLSSDILPRWAIIGWLLTTCTSLKQRLGKSNIQARLGRPIGALARGAIGGRGLPIIQRGLPRGGLRGGRATRTLLRGG MSLRGQNLLRGGRAVAPRMGLRRGGVRGRGGPGRGGLGRGAMGRGGIGGRGRGMIGRGRGGFGGRGRGRGRGRGALARPVLTKEQLDNQL -------------------------------------------------------------- >39936_39936_7_INTS3-CHTOP_INTS3_chr1_153730239_ENST00000456435_CHTOP_chr1_153614718_ENST00000368694_length(amino acids)=568AA_BP=393 MTFSRLLAAAMELQKGKGAAAAAAASGAAGGGGGGAGAGAPGGGRLLLSTSLDAKDELEERLERCMSIVTSMTAGVSEREANDALNAYVC KGLPQHEEICLGLFTLILTEPAQAQKCYRDLALVSRDGMNIVLNKINQILMEKYLKLQDTCRTQLVWLVRELVKSGVLGADGVCMTFMKQ IAGGDVTAKNIWLAESVLDILTEQREWVLKSSILIAMAVYTYLRLIVDHHGTAQLQALRQKEVDFCISLLRERFMECLMIGRDLVRLLQN VARIPEFELLWKDIIHNPQALSPQFTGILQLLQSRTSRKFLACRLTPDMETKLLFMTSRVRFGQQKRYQDWFQRQYLSTPDSQSLRCDLI RYICGVVHPSNEVLSSDILPRWAIIGWLLTTCTSLKQRLGKSNIQARLGRPIGALARGAIGGRGLPIIQRGLPRGGLRGGRATRTLLRGG MSLRGQNLLRGGRAVAPRMGLRRGGVRGRGGPGRGGLGRGAMGRGGIGGRGRGMIGRGRGGFGGRGRGRGRGRGALARPVLTKEQLDNQL -------------------------------------------------------------- >39936_39936_8_INTS3-CHTOP_INTS3_chr1_153730239_ENST00000456435_CHTOP_chr1_153614719_ENST00000368694_length(amino acids)=568AA_BP=393 MTFSRLLAAAMELQKGKGAAAAAAASGAAGGGGGGAGAGAPGGGRLLLSTSLDAKDELEERLERCMSIVTSMTAGVSEREANDALNAYVC KGLPQHEEICLGLFTLILTEPAQAQKCYRDLALVSRDGMNIVLNKINQILMEKYLKLQDTCRTQLVWLVRELVKSGVLGADGVCMTFMKQ IAGGDVTAKNIWLAESVLDILTEQREWVLKSSILIAMAVYTYLRLIVDHHGTAQLQALRQKEVDFCISLLRERFMECLMIGRDLVRLLQN VARIPEFELLWKDIIHNPQALSPQFTGILQLLQSRTSRKFLACRLTPDMETKLLFMTSRVRFGQQKRYQDWFQRQYLSTPDSQSLRCDLI RYICGVVHPSNEVLSSDILPRWAIIGWLLTTCTSLKQRLGKSNIQARLGRPIGALARGAIGGRGLPIIQRGLPRGGLRGGRATRTLLRGG MSLRGQNLLRGGRAVAPRMGLRRGGVRGRGGPGRGGLGRGAMGRGGIGGRGRGMIGRGRGGFGGRGRGRGRGRGALARPVLTKEQLDNQL -------------------------------------------------------------- >39936_39936_9_INTS3-CHTOP_INTS3_chr1_153730239_ENST00000456435_CHTOP_chr1_153614722_ENST00000368694_length(amino acids)=568AA_BP=393 MTFSRLLAAAMELQKGKGAAAAAAASGAAGGGGGGAGAGAPGGGRLLLSTSLDAKDELEERLERCMSIVTSMTAGVSEREANDALNAYVC KGLPQHEEICLGLFTLILTEPAQAQKCYRDLALVSRDGMNIVLNKINQILMEKYLKLQDTCRTQLVWLVRELVKSGVLGADGVCMTFMKQ IAGGDVTAKNIWLAESVLDILTEQREWVLKSSILIAMAVYTYLRLIVDHHGTAQLQALRQKEVDFCISLLRERFMECLMIGRDLVRLLQN VARIPEFELLWKDIIHNPQALSPQFTGILQLLQSRTSRKFLACRLTPDMETKLLFMTSRVRFGQQKRYQDWFQRQYLSTPDSQSLRCDLI RYICGVVHPSNEVLSSDILPRWAIIGWLLTTCTSLKQRLGKSNIQARLGRPIGALARGAIGGRGLPIIQRGLPRGGLRGGRATRTLLRGG MSLRGQNLLRGGRAVAPRMGLRRGGVRGRGGPGRGGLGRGAMGRGGIGGRGRGMIGRGRGGFGGRGRGRGRGRGALARPVLTKEQLDNQL -------------------------------------------------------------- >39936_39936_10_INTS3-CHTOP_INTS3_chr1_153730239_ENST00000512605_CHTOP_chr1_153614718_ENST00000368694_length(amino acids)=360AA_BP=185 MKSSILIAMAVYTYLRLIVDHHGTAQLQALRQKEVDFCISLLRERFMECLMIGRDLVRLLQNVARIPEFELLWKDIIHNPQALSPQFTGI LQLLQSRTSRKFLACRLTPDMETKLLFMTSRVRFGQQKRYQDWFQRQYLSTPDSQSLRCDLIRYICGVVHPSNEVLSSDILPRWAIIGWL LTTCTSLKQRLGKSNIQARLGRPIGALARGAIGGRGLPIIQRGLPRGGLRGGRATRTLLRGGMSLRGQNLLRGGRAVAPRMGLRRGGVRG RGGPGRGGLGRGAMGRGGIGGRGRGMIGRGRGGFGGRGRGRGRGRGALARPVLTKEQLDNQLDAYMSKTKGHLDAELDAYMAQTDPETND -------------------------------------------------------------- >39936_39936_11_INTS3-CHTOP_INTS3_chr1_153730239_ENST00000512605_CHTOP_chr1_153614719_ENST00000368694_length(amino acids)=360AA_BP=185 MKSSILIAMAVYTYLRLIVDHHGTAQLQALRQKEVDFCISLLRERFMECLMIGRDLVRLLQNVARIPEFELLWKDIIHNPQALSPQFTGI LQLLQSRTSRKFLACRLTPDMETKLLFMTSRVRFGQQKRYQDWFQRQYLSTPDSQSLRCDLIRYICGVVHPSNEVLSSDILPRWAIIGWL LTTCTSLKQRLGKSNIQARLGRPIGALARGAIGGRGLPIIQRGLPRGGLRGGRATRTLLRGGMSLRGQNLLRGGRAVAPRMGLRRGGVRG RGGPGRGGLGRGAMGRGGIGGRGRGMIGRGRGGFGGRGRGRGRGRGALARPVLTKEQLDNQLDAYMSKTKGHLDAELDAYMAQTDPETND -------------------------------------------------------------- >39936_39936_12_INTS3-CHTOP_INTS3_chr1_153730239_ENST00000512605_CHTOP_chr1_153614722_ENST00000368694_length(amino acids)=360AA_BP=185 MKSSILIAMAVYTYLRLIVDHHGTAQLQALRQKEVDFCISLLRERFMECLMIGRDLVRLLQNVARIPEFELLWKDIIHNPQALSPQFTGI LQLLQSRTSRKFLACRLTPDMETKLLFMTSRVRFGQQKRYQDWFQRQYLSTPDSQSLRCDLIRYICGVVHPSNEVLSSDILPRWAIIGWL LTTCTSLKQRLGKSNIQARLGRPIGALARGAIGGRGLPIIQRGLPRGGLRGGRATRTLLRGGMSLRGQNLLRGGRAVAPRMGLRRGGVRG RGGPGRGGLGRGAMGRGGIGGRGRGMIGRGRGGFGGRGRGRGRGRGALARPVLTKEQLDNQLDAYMSKTKGHLDAELDAYMAQTDPETND -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:153730239/chr1:153614719) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| INTS3 | CHTOP |
| FUNCTION: Component of the Integrator (INT) complex. The Integrator complex is involved in the small nuclear RNAs (snRNA) U1 and U2 transcription and in their 3'-box-dependent processing. The Integrator complex is associated with the C-terminal domain (CTD) of RNA polymerase II largest subunit (POLR2A) and is recruited to the U1 and U2 snRNAs genes (Probable). Mediates recruitment of cytoplasmic dynein to the nuclear envelope, probably as component of the INT complex (PubMed:23904267). {ECO:0000269|PubMed:23904267, ECO:0000305|PubMed:16239144}.; FUNCTION: Component of the SOSS complex, a multiprotein complex that functions downstream of the MRN complex to promote DNA repair and G2/M checkpoint. The SOSS complex associates with single-stranded DNA at DNA lesions and influences diverse endpoints in the cellular DNA damage response including cell-cycle checkpoint activation, recombinational repair and maintenance of genomic stability. The SOSS complex is required for efficient homologous recombination-dependent repair of double-strand breaks (DSBs) and ATM-dependent signaling pathways. In the SOSS complex, it is required for the assembly of the complex and for stabilization of the complex at DNA damage sites. {ECO:0000269|PubMed:19605351, ECO:0000269|PubMed:19683501}. | FUNCTION: Plays an important role in the ligand-dependent activation of estrogen receptor target genes (PubMed:19858291). May play a role in the silencing of fetal globin genes (PubMed:20688955). Recruits the 5FMC complex to ZNF148, leading to desumoylation of ZNF148 and subsequent transactivation of ZNF148 target genes (By similarity). Plays an important role in the tumorigenicity of glioblastoma cells. Binds to 5-hydroxymethylcytosine (5hmC) and associates with the methylosome complex containing PRMT1, PRMT5, MEP50 and ERH. The CHTOP-methylosome complex associated with 5hmC is recruited to selective sites on the chromosome, where it methylates H4R3 and activates the transcription of genes involved in glioblastomagenesis (PubMed:25284789). {ECO:0000250|UniProtKB:Q9CY57, ECO:0000269|PubMed:19858291, ECO:0000269|PubMed:20688955, ECO:0000269|PubMed:25284789}.; FUNCTION: Required for effective mRNA nuclear export and is a component of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NFX1 pathway. The TREX complex is essential for the export of Kaposi's sarcoma-associated herpesvirus (KSHV) intronless mRNAs and infectious virus production. Stimulates DDX39B ATPase and helicase activities. In cooperation with ALYREF/THOC4 enhances NXF1 RNA binding activity (PubMed:23299939). {ECO:0000269|PubMed:23299939}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - Retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | INTS3 | chr1:153730239 | chr1:153614718 | ENST00000318967 | + | 10 | 30 | 9_34 | 383.0 | 1043.0 | Compositional bias | Note=Ala/Gly-rich |
| Hgene | INTS3 | chr1:153730239 | chr1:153614718 | ENST00000435409 | + | 11 | 31 | 9_34 | 383.0 | 1043.0 | Compositional bias | Note=Ala/Gly-rich |
| Hgene | INTS3 | chr1:153730239 | chr1:153614718 | ENST00000456435 | + | 10 | 29 | 9_34 | 177.0 | 903.0 | Compositional bias | Note=Ala/Gly-rich |
| Hgene | INTS3 | chr1:153730239 | chr1:153614718 | ENST00000512605 | + | 4 | 23 | 9_34 | 177.0 | 903.0 | Compositional bias | Note=Ala/Gly-rich |
| Hgene | INTS3 | chr1:153730239 | chr1:153614719 | ENST00000318967 | + | 10 | 30 | 9_34 | 383.0 | 1043.0 | Compositional bias | Note=Ala/Gly-rich |
| Hgene | INTS3 | chr1:153730239 | chr1:153614719 | ENST00000435409 | + | 11 | 31 | 9_34 | 383.0 | 1043.0 | Compositional bias | Note=Ala/Gly-rich |
| Hgene | INTS3 | chr1:153730239 | chr1:153614719 | ENST00000456435 | + | 10 | 29 | 9_34 | 177.0 | 903.0 | Compositional bias | Note=Ala/Gly-rich |
| Hgene | INTS3 | chr1:153730239 | chr1:153614719 | ENST00000512605 | + | 4 | 23 | 9_34 | 177.0 | 903.0 | Compositional bias | Note=Ala/Gly-rich |
| Hgene | INTS3 | chr1:153730239 | chr1:153614722 | ENST00000318967 | + | 10 | 30 | 9_34 | 383.0 | 1043.0 | Compositional bias | Note=Ala/Gly-rich |
| Hgene | INTS3 | chr1:153730239 | chr1:153614722 | ENST00000435409 | + | 11 | 31 | 9_34 | 383.0 | 1043.0 | Compositional bias | Note=Ala/Gly-rich |
| Hgene | INTS3 | chr1:153730239 | chr1:153614722 | ENST00000456435 | + | 10 | 29 | 9_34 | 177.0 | 903.0 | Compositional bias | Note=Ala/Gly-rich |
| Hgene | INTS3 | chr1:153730239 | chr1:153614722 | ENST00000512605 | + | 4 | 23 | 9_34 | 177.0 | 903.0 | Compositional bias | Note=Ala/Gly-rich |
| Tgene | CHTOP | chr1:153730239 | chr1:153614718 | ENST00000368690 | 1 | 4 | 87_208 | 73.0 | 203.0 | Compositional bias | Note=Arg/Gly-rich | |
| Tgene | CHTOP | chr1:153730239 | chr1:153614718 | ENST00000368694 | 2 | 6 | 87_208 | 73.0 | 249.0 | Compositional bias | Note=Arg/Gly-rich | |
| Tgene | CHTOP | chr1:153730239 | chr1:153614718 | ENST00000403433 | 2 | 5 | 87_208 | 73.0 | 203.0 | Compositional bias | Note=Arg/Gly-rich | |
| Tgene | CHTOP | chr1:153730239 | chr1:153614719 | ENST00000368690 | 1 | 4 | 87_208 | 73.0 | 203.0 | Compositional bias | Note=Arg/Gly-rich | |
| Tgene | CHTOP | chr1:153730239 | chr1:153614719 | ENST00000368694 | 2 | 6 | 87_208 | 73.0 | 249.0 | Compositional bias | Note=Arg/Gly-rich | |
| Tgene | CHTOP | chr1:153730239 | chr1:153614719 | ENST00000403433 | 2 | 5 | 87_208 | 73.0 | 203.0 | Compositional bias | Note=Arg/Gly-rich | |
| Tgene | CHTOP | chr1:153730239 | chr1:153614722 | ENST00000368690 | 1 | 4 | 87_208 | 73.0 | 203.0 | Compositional bias | Note=Arg/Gly-rich | |
| Tgene | CHTOP | chr1:153730239 | chr1:153614722 | ENST00000368694 | 2 | 6 | 87_208 | 73.0 | 249.0 | Compositional bias | Note=Arg/Gly-rich | |
| Tgene | CHTOP | chr1:153730239 | chr1:153614722 | ENST00000403433 | 2 | 5 | 87_208 | 73.0 | 203.0 | Compositional bias | Note=Arg/Gly-rich | |
| Tgene | CHTOP | chr1:153730239 | chr1:153614718 | ENST00000368690 | 1 | 4 | 194_203 | 73.0 | 203.0 | Motif | GAR motif%3B involved in 5hmC binding | |
| Tgene | CHTOP | chr1:153730239 | chr1:153614718 | ENST00000368694 | 2 | 6 | 194_203 | 73.0 | 249.0 | Motif | GAR motif%3B involved in 5hmC binding | |
| Tgene | CHTOP | chr1:153730239 | chr1:153614718 | ENST00000403433 | 2 | 5 | 194_203 | 73.0 | 203.0 | Motif | GAR motif%3B involved in 5hmC binding | |
| Tgene | CHTOP | chr1:153730239 | chr1:153614719 | ENST00000368690 | 1 | 4 | 194_203 | 73.0 | 203.0 | Motif | GAR motif%3B involved in 5hmC binding | |
| Tgene | CHTOP | chr1:153730239 | chr1:153614719 | ENST00000368694 | 2 | 6 | 194_203 | 73.0 | 249.0 | Motif | GAR motif%3B involved in 5hmC binding | |
| Tgene | CHTOP | chr1:153730239 | chr1:153614719 | ENST00000403433 | 2 | 5 | 194_203 | 73.0 | 203.0 | Motif | GAR motif%3B involved in 5hmC binding | |
| Tgene | CHTOP | chr1:153730239 | chr1:153614722 | ENST00000368690 | 1 | 4 | 194_203 | 73.0 | 203.0 | Motif | GAR motif%3B involved in 5hmC binding | |
| Tgene | CHTOP | chr1:153730239 | chr1:153614722 | ENST00000368694 | 2 | 6 | 194_203 | 73.0 | 249.0 | Motif | GAR motif%3B involved in 5hmC binding | |
| Tgene | CHTOP | chr1:153730239 | chr1:153614722 | ENST00000403433 | 2 | 5 | 194_203 | 73.0 | 203.0 | Motif | GAR motif%3B involved in 5hmC binding |
| - Not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Protein Structures |
| PDB and CIF files of the predicted fusion proteins * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
| Fusion protein PDB link (fusion AA seq ID in FusionPDB) | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | AA seq | Len(AA seq) |
| PDB file >>>1212_INTS3_153730239_CHTOP_153614719_1212_INTS3_153730239_CHTOP_153614719_ranked_0.pdb | INTS3 | 153730239 | 153730239 | ENST00000368694 | CHTOP | chr1 | 153614719 | + | MTFSRLLAAAMELQKGKGAAAAAAASGAAGGGGGGAGAGAPGGGRLLLSTSLDAKDELEERLERCMSIVTSMTAGVSEREANDALNAYVC KGLPQHEEICLGLFTLILTEPAQAQKCYRDLALVSRDGMNIVLNKINQILMEKYLKLQDTCRTQLVWLVRELVKSGVLGADGVCMTFMKQ IAGGDVTAKNIWLAESVLDILTEQREWVLKSSILIAMAVYTYLRLIVDHHGTAQLQALRQKEVDFCISLLRERFMECLMIGRDLVRLLQN VARIPEFELLWKDIIHNPQALSPQFTGILQLLQSRTSRKFLACRLTPDMETKLLFMTSRVRFGQQKRYQDWFQRQYLSTPDSQSLRCDLI RYICGVVHPSNEVLSSDILPRWAIIGWLLTTCTSLKQRLGKSNIQARLGRPIGALARGAIGGRGLPIIQRGLPRGGLRGGRATRTLLRGG MSLRGQNLLRGGRAVAPRMGLRRGGVRGRGGPGRGGLGRGAMGRGGIGGRGRGMIGRGRGGFGGRGRGRGRGRGALARPVLTKEQLDNQL | 568 |
Top |
pLDDT score distribution |
| pLDDT score distribution of the predicted wild-type structures of two partner proteins from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
INTS3_pLDDT.png  |
CHTOP_pLDDT.png  |
| pLDDT score distribution of the predicted fusion protein structures from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
 |
Top |
Ramachandran Plot of Fusion Protein Structure |
| Ramachandran plot of the torsional angles - phi (φ)and psi (ψ) - of the residues (amino acids) contained in this fusion protein peptide. |
| Fusion AA seq ID in FusionPDB and their Ramachandran plots |
Top |
Fusion Protein-Protein Interaction |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
| Gene | PPI interactors |
| Protein-protein interactors based on sequence similarity (STRING) |
| Gene | STRING network |
| INTS3 | |
| CHTOP |
| - Retained interactions in fusion protein (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost interactions due to fusion (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to INTS3-CHTOP |
| Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to INTS3-CHTOP |
| Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Disease | Source | PMID |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies